Hepatitis c inhibitor compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/14 (2006.01) A61K 31/4709 (2006.01) A61K 31/506 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2737958

Compounds of Formula (I): wherein B, R3, L0, L1, R2, R c and R1 are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection. In particular, the present invention provides novel peptide analogs, pharmaceutical compositions containing such analogs, and uses of these analogs in the treatment of HCV infection

L'invention porte sur des composés représentés par la formule (I) : dans laquelle B, R3, L0, L1, R2, Rc et R1 sont tels que définis dans la description. Les composés sont utiles comme inhibiteurs de la protéase NS3 du VHC pour le traitement d'une infection virale de type hépatite C. En particulier, la présente invention porte sur de nouveaux analogues peptidiques, sur des compositions pharmaceutiques contenant de tels analogues et sur des utilisations de ces analogues dans le traitement d'une infection à VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hepatitis c inhibitor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis c inhibitor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis c inhibitor compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2087149

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.